Citadel Advisors’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History
Bought
Maintained
Sold
Other funds holding SWAV
SA
UWS
IA
BTI
MG
Citadel Advisors's SWAV Position: Q2 2024 in Review
Citadel Advisors sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 495,358 shares — an estimated $161M sold.
Citadel Advisors first reported a position in SWAV in Q1 2019 and held it in 20 quarters. The position peaked at $170M in Q4 2023. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.
- Citadel Advisors reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- Citadel Advisors sold 495,358 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $161M.
- Citadel Advisors first reported a position in Shockwave Medical, Inc. Common Stock in Q1 2019 and held it in 20 quarters.
- Citadel Advisors's Shockwave Medical, Inc. Common Stock position peaked at $170M in Q4 2023.
- 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.
Based on Citadel Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.